A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies-Reference-Cited by-同舟云学术

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies

Published:2018-02-01 Issue:3 Volume:81 Page:587-596
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Deeken John F.^ORCID,Wang Hongkun,Hartley Marion,Cheema Amrita K.,Smaglo Brandon,Hwang Jimmy J.,He Aiwu Ruth,Weiner Louis M.,Marshall John L.,Giaccone Giuseppe,Liu Stephen,Luecht Jim,Spiegel Jay Y.,Pishvaian Michael J.

Funder

Ruesch Center for the Cure of Gastrointestinal Cancers

National Cancer Institute

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/article/10.1007/s00280-018-3533-8/fulltext.html

Reference45 articles.

1. Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y (1993) Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother 37(5):1108–1114

2. Lin AJ, Ager AL Jr, Klayman DL (1994) The antimalarial activity of dihydroartemisinin derivatives by transdermal application. Am J Trop Med Hyg 50(6):777–783

3. Lai H, Singh NP (1995) Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91:41–46

4. Moore Lai H, Li JR, Ren RL, McDougall JA, Singh NP, Choud CK (1995) Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett 98:83–87

5. Nakase I, Lai H, Singh NP, Sasaki T (2008) Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 354:28–33

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New hydrazide derivatives of N‐amino‐11‐azaartemisinin as promising epidermal growth factor receptor inhibitors for therapeutic development in triple‐negative breast cancer;Archiv der Pharmazie;2024-09-13

2. Artemisinin and Its Derivatives as Potential Anticancer Agents;Molecules;2024-08-16

3. Enhancement of Anticancer Potential of Artemisinin Derivatives through N-glycosylation;Current Topics in Medicinal Chemistry;2024-08-12

4. Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1;Cell Communication and Signaling;2024-07-26

5. Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer;Cancers;2024-03-28